Merck Limited (MERCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Merck Limited (Merck India), formerly E. Merck Limited, manufactures and markets pharmaceutical products, over-the-counter (OTC) products, fine chemicals and pigments. It operates through two businesses, namely, Pharmaceuticals and Chemicals. The Pharmaceuticals segment manufactures prescription drugs and OTC products through its divisions Merck Serono and Consumer Health Care. It markets pharmaceutical products under the brand names of Neurobion, Polybion, Evion, Livogen Concor, Nasivion, Seven Seas and Maxepa, among others. The Chemicals segment offers Performance Materials and Pharm Chem Solutions. The segment’s product portfolio includes active pharmaceutical ingredients (APIs), biopharmaceuticals and pigments, among others. The company’s chemical products find application in the electronics, food, pharmaceutical, printing, coatings, cosmetics and biotechnology industries. It operates mainly in India and exports its products to Asian and African countries such as Nepal, Lebanon, Kenya, Sri Lanka and Libya, among others. It is a subsidiary of Merck KGaA. Merck India is headquartered in Mumbai, Maharashtra, India.
Merck Limited Key Recent Developments
Apr 26, 2013: Merck India Reports Revenue Of INR1.8 Billion In Q1 2013 Jan 30, 2013: Merck India Reports Revenue Of INR6.6 Billion In 2012
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table Of Contents
Merck Limited (MERCK) - Financial and Strategic SWOT Analysis Review Table of Contents Section 1 - About the Company 6 Merck Limited - Key Facts 6 Merck Limited - Key Employees 7 Merck Limited - Major Products and Services 8 Merck Limited - History 11 Merck Limited - Company Statement 12 Merck Limited - Locations And Subsidiaries 13 Head Office 13 Other Locations and Subsidiaries 13 Section 2 - Company Analysis 14 Merck Limited - Business Description 14 Merck Limited - Corporate Strategy 15 Merck Limited - SWOT Analysis 16 SWOT Analysis - Overview 16 Merck Limited - Strengths 16 Strength - Growing Segments 16 Strength - Research and Development Capabilities 16 Merck Limited - Weaknesses 17 Weakness - Declined Operational Performance 17 Weakness - Breach of Law 17 Weakness - Operational Constraints 17 Merck Limited - Opportunities 18 Opportunity - Pipeline Products 18 Opportunity - Paints and Coatings Market 18 Opportunity - Growing Aged Population 18 Opportunity - Growth Potential: India 18 Merck Limited - Threats 19 Threat - Uncertain RandD Outcomes 19 Threat - Stringent Government Regulations 19 Threat - Intense Competition 19 Threat - Anti Dumping Duty 19 Merck Limited - Key Competitors 20 Section 3 - Company Financial Ratios 21 Financial Ratios - Capital Market Ratios 21 Financial Ratios - Annual Ratios 22 Performance Chart 24 Financial Performance 24 Financial Ratios - Interim Ratios 25 Financial Ratios - Ratio Charts 26 Section 4 - Company's Recent Developments 27 Dec 18, 2014: Merck Announces Resignation Of Claus-Dieter Boedecker 27 Nov 26, 2014: Merck commissioned a climate-neutral co-generation plant at its production site in Goa, India. 28 Section 5 - Appendix 29 Methodology 29 Ratio Definitions 29 About GlobalData 33 Contact Us 33 Disclaimer 33
List of Tables
Merck Limited, Key Facts 6 Merck Limited, Key Employees 7 Merck Limited, Major Products and Services 8 Merck Limited, History 11 Merck Limited, Other Locations 13 Merck Limited, Key Competitors 20 Merck Limited, Ratios based on current share price 21 Merck Limited, Annual Ratios 22 Merck Limited, Interim Ratios 25 Currency Codes 29 Capital Market Ratios 29 Equity Ratios 30 Profitability Ratios 30 Cost Ratios 31 Liquidity Ratios 31 Leverage Ratios 32 Efficiency Ratios 32